Advertisement
Screener

Quantum Cyber N.V. (QUCY) EBITDA

Quantum Cyber N.V. (QUCY) EBITDA

  • 2026-06-30: Basis Reported; EBITDA -$9.89M*; Operating income -$9.89M; Depreciation and amortization -$2.29K*.
  • 2026-03-31: Basis Reported; EBITDA -$2.41M; Operating income (m); Depreciation and amortization (m).
  • 2025-06-30: Basis Reported; EBITDA -$1.46M*; Operating income -$1.63M; Depreciation and amortization $167.01K*.
  • 2025-03-31: Basis Reported; EBITDA -$2.58M; Operating income (m); Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2024-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported-$9.89M*-$9.89M-$2.29K*(m)(m)$136.80K*-$7.19M*(m)$4.55M(m)(m)
2026-03-31Reported-$2.41M(m)(m)(m)(m)$658.00-$2.71M(m)$59.30K(m)(m)
2025-06-30Reported-$1.46M*-$1.63M$167.01K*(m)(m)$0.00*-$2.68M*(m)$101.28K(m)(m)
2025-03-31Reported-$2.58M(m)(m)(m)(m)$1.22K-$3.94M(m)$88.75K(m)(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported-$15.52M(m)(m)(m)-2890.33%$1.22K-$10.98M(m)$4.91M(m)(m)
2024-12-31Reported-$18.08M(m)(m)(m)-2022.01%$104.95K-$17.33M(m)$5.72M(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Immuneering Corp (IMRX)United States$0.113B-12.51
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
GENELUX Corp (GNLX)United States$0.110B-3.83
Equillium, Inc. (EQ)United States$0.109B-11.27
Biomea Fusion, Inc. (BMEA)United States$0.107B-3.30
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
Polaryx Therapeutics, Inc. (PLYX)United States$0.106B
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
CUMBERLAND PHARMACEUTICALS INC (CPIX)United States$0.121B-8.95
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80